JPML Weighs New Opioid MDL As McKinsey Suits Surge

By Jeff Overley · May 27, 2021, 8:23 PM EDT

New multidistrict litigation probably won't streamline dozens of cases accusing McKinsey & Co. of helping drugmakers aggressively market prescription opioids, but squeezing the cases into a long-running opioid MDL might be...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Case Title

IN RE: McKinsey & Company, Inc., National Prescription Opiate Consultant Litigation

Case Number

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Date Filed

March 05, 2021

Recent Articles By Jeff

July 05, 2024
How Reshaped Circuit Courts Are Faring At The High Court
July 05, 2024
The Funniest Moments Of The Supreme Court's Term
June 29, 2024
Chevron's End Is Just The Start For Energized Agency Foes
June 17, 2024
Teva, DOJ Signal Key Kickback Case May Fizzle At 1st Circ.
March 29, 2024
Hogan Lovells Vet's High Court Debut A Study In Contrasts
January 29, 2024
The Top Attys In Clinton's Impeachment Trial, 25 Years Later
January 18, 2024
'Chaos' Warning Resonates As Justices Mull Chevron's Fate
January 01, 2024
Appellate Outlook: Circuit Splits & Hot Topics To Track In 2024
December 09, 2023
Circuit-By-Circuit Guide To 2023's Most Memorable Moments
November 09, 2023
Paul Clement's Big Idea: Overrule Chevron, Ease Polarization